Not arguing that point Duty, hoorah A2 and all that, just the studies to try and show A1 causing inflammation in humans are not going to be feasible. I look at gut biopsies for a living, it is highly unlikely that this line of research will be useful. People will decide on based upon experience with the product when they try it. Better to focus on A2 being the closest to human milk, best for baby. Simple message and where the big bucks are.
A2 doubles production - demand still increasing, page-15
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.79 |
Change
-0.120(1.74%) |
Mkt cap ! $4.937B | |||
| Open | High | Low | Value | Volume |
| $6.83 | $6.87 | $6.78 | $4.597M | 676.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 7146 | $6.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.80 | 11936 | 30 |
View Market Depth
| Last trade - 15.46pm 19/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |